Regional Health Propertie... (RHE)
AMEX: RHE
· Real-Time Price · USD
2.77
-0.00 (-0.15%)
At close: Feb 03, 2025, 2:05 PM
Regional Health Properties Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 21.4M | 18.34M | 17.2M | 17.11M | 17.39M | 17.16M | 22.8M | 29.69M | 33.18M | 35.93M | 32.21M | 27.88M | 26.26M | 26.69M | 23.98M | 22.04M | 20.11M |
Cost of Revenue | 8.3M | 11.06M | 10.94M | 11.23M | 10.84M | 10.91M | 14.62M | 21.07M | 24.62M | 25.95M | 23.31M | 18.49M | 16.53M | 16.38M | 14.13M | 11.68M | 9.45M |
Gross Profit | 5.91M | 7.27M | 6.26M | 5.88M | 6.54M | 6.26M | 8.17M | 8.62M | 8.57M | 9.97M | 8.9M | 9.39M | 9.72M | 10.31M | 9.85M | 10.36M | 10.66M |
Operating Income | 137K | 161K | -220K | -324K | -352K | -787K | 1.96M | 4.07M | 3.36M | 2.75M | 127K | -953K | 124K | 2.58M | 1.99M | 1.99M | 2.53M |
Interest Income | n/a | n/a | n/a | n/a | 679K | 1.36M | 2.03M | 2.6M | 1.92M | 1.24M | 564K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -4.12M | -3.22M | -2.89M | -2.88M | -2.86M | -3.89M | -5.89M | -5.29M | -5.93M | -6.87M | -5.34M | -4.98M | -4.1M | -1.14M | -1.39M | -1.44M | -593K |
Net Income | -4.12M | -3.22M | -2.89M | -2.88M | -2.86M | -3.89M | -10.38M | -9.77M | -10.42M | -12.91M | -6.85M | -6.52M | -5.7M | -1.18M | -1.53M | -1.57M | -653K |
Selling & General & Admin | 6.01M | 5.41M | 4.87M | 4.62M | 4.4M | 3.98M | 4.41M | 4.82M | 4.72M | 4.64M | 4.37M | 3.97M | 3.99M | 3.9M | 3.99M | 3.76M | 3.53M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 2.19M | 531K | -1.49M | -2.33M | -3.07M | -805K | 1.7M | 2.6M | 4.49M | 6.59M | 5.09M | 3.93M | 1.91M | -1.19M | -816K | -703K | -371K |
Operating Expenses | 8.2M | 7.63M | 6.99M | 6.72M | 6.9M | 7.04M | 8.06M | 8.55M | 9.22M | 11.24M | 10.94M | 10.35M | 9.6M | 7.73M | 7.86M | 8.37M | 8.13M |
Interest Expense | 2.69M | 2.71M | 2.71M | 2.74M | 2.75M | 2.75M | 2.74M | 2.6M | 2.56M | 2.53M | 2.5M | 2.61M | 2.63M | 2.67M | 2.71M | 2.73M | 2.75M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 13.76M | 18.18M | 17.42M | 17.44M | 17.74M | 17.95M | 22.68M | 29.63M | 33.84M | 37.19M | 34.25M | 28.84M | 26.13M | 24.11M | 21.98M | 20.05M | 17.59M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 2.82K | 4.48M | 4.48M | 4.48M | 6.05M | 1.57M | 1.57M | 1.57M | 4.57K | 3.95K | 6.2K | 6.13K |
Shares Outstanding (Basic) | 1.99M | 1.93M | 1.9M | 1.85M | 1.84M | 1.84M | 1.88M | 1.88M | 1.86M | 1.77M | 1.77M | 1.77M | 1.79M | 1.75M | 1.77M | 1.7M | 1.69M |
Shares Outstanding (Diluted) | 1.99M | 1.93M | 1.9M | 1.85M | 1.84M | 1.84M | 1.88M | 1.88M | 1.86M | 1.77M | 1.77M | 1.77M | 1.79M | 1.77M | 1.77M | 1.7M | 1.69M |
EPS (Basic) | -2.13 | -1.71 | -1.55 | -1.55 | -1.53 | -2.08 | -5.75 | -5.44 | -5.83 | -7.27 | -3.85 | -3.66 | -3.21 | -0.69 | -0.91 | -0.93 | -0.39 |
EPS (Diluted) | -2.13 | -1.71 | -1.55 | -1.55 | -1.53 | -2.08 | -5.75 | -5.44 | -5.83 | -7.27 | -3.84 | -3.65 | -3.2 | -0.68 | -0.91 | -0.93 | -0.39 |
EBITDA | 1.67M | 1.8M | 1.8M | 1.75M | 1.91M | 1.45M | -210K | 1.98M | 1.09M | 597.08K | 2.51M | 1.48M | 2.68M | 5.17M | 4.6M | 3.95M | 3.92M |
EBIT | -539K | -515K | -189K | -149K | 74K | -944K | -1.5M | -1.05M | -1.92M | -2.88M | -2.48M | -2.04M | -1.19M | 1.79M | 1.23M | 1.22M | 2.14M |
Depreciation & Amortization | 1.95M | 2.06M | 2.02M | 2.07M | 2.26M | 2.25M | 2.32M | 2.4M | 2.3M | 2.4M | 2.46M | 2.51M | 2.55M | 2.59M | 2.61M | 2.65M | 2.77M |